McNeill Jonathan
- SEC CIK
- 0001824673
In the past year, 2 open-market sale filings worth $446.9K and no purchases.
Current role at each company
- CBIO Crescent Biopharma, Inc.President and COOas of Sep 18, 2026
- DYN Dyne Therapeutics, Inc.Chief Business Officeras of Aug 20, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $446.9K
- 2 filings
- Net
- −$446.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists McNeill Jonathan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CBIO Crescent Biopharma, Inc.
President and COO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 (view filing)4:01 PM ET | Sep 16-18 | 2 days | McNeill JonathanPresident and COO | SSale | −4.57K | $16.90 | −$77.2K | −3.3%134.6K after | 2 lots10b5-1 |
| Jun 23, 2026 (view filing) | Jun 22 | 1 day | McNeill JonathanPresident and COO | SSale | −20.5K | $17.99 | −$369.7K | −12.9%139.2K after | 10b5-1 |
DYN Dyne Therapeutics, Inc.
Chief Business Officer18 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2024 (view filing) | Aug 19 | 1 day | McNeill JonathanChief Business Officer | SSale | −2.71K | $45.12 | −$122.1K | −2.0%132.1K after | 2 lots10b5-1 |
| Jun 11, 2024 (view filing) | Jun 11 | Same day | McNeill JonathanChief Business Officer | SSale | −1.82K | $31.34 | −$57.1K | −1.3%134.8K after | |
| May 17, 2024 (view filing) | May 16 | 1 day | McNeill JonathanChief Business Officer | SSale | −2.77K | $28.27 | −$78.4K | −2.0%136.6K after | 2 lots10b5-1 |
| Mar 13, 2024 (view filing)6:04 AM ET | Mar 8-11 | 5 daysLate | McNeill JonathanChief Business Officer | SSale | −109.6K | $26.11 | −$2.86M | −44.0%139.4K after | 5 lots10b5-1 |
| Mar 11, 2024 (view filing) | Mar 7 | 4 days | McNeill JonathanChief Business Officer | SSale | −2.43K | $25.85 | −$62.9K | −1.7%141.2K after | 10b5-1 |
| Mar 1, 2024 (view filing) | Feb 29-Mar 1 | 1 day | McNeill JonathanChief Business Officer | SSale | −28.5K | $28.46 | −$811.9K | −16.6%143.6K after | 4 lots10b5-1 |
| Jan 26, 2024 (view filing) | Jan 26 | Same day | McNeill JonathanChief Business Officer | SSale | −20.0K | $24.53 | −$490.5K | −12.2%143.6K after | 2 lots10b5-1 |
| Jan 4, 2024 (view filing) | Jan 2-4 | 2 days | McNeill JonathanChief Business Officer | SSale | −31.9K | $16.59 | −$529.2K | −18.2%143.6K after | 4 lots10b5-1 |
| Dec 12, 2023 (view filing) | Dec 11 | 1 day | McNeill JonathanChief Business Officer | SSale | −1.25K | $10.72 | −$13.3K | −0.8%155.5K after | |
| Sep 20, 2023 (view filing) | Sep 18 | 2 days | McNeill JonathanChief Business Officer | SSale | −1.26K | $9.41 | −$11.9K | −2.0%60.6K after |